In order to investigate the safety and efficacy of 68Ga-labeled GRPR antagonist SB3 in PET/CT imaging of primary PC, Ingrid L. Bakker et al. conducted a study focusing on the biological distribution, dosimetry, pathology, and GRPR expression. The gene discussed is GRPR; the disease is pachyonychia congenita.